OmniAb Correlations
OABI Stock | USD 3.90 0.12 3.17% |
The current 90-days correlation between OmniAb Inc and Ideaya Biosciences is 0.31 (i.e., Weak diversification). The correlation of OmniAb is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
OmniAb Correlation With Market
Weak diversification
The correlation between OmniAb Inc and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding OmniAb Inc and DJI in the same portfolio, assuming nothing else is changed.
OmniAb |
Moving together with OmniAb Stock
Moving against OmniAb Stock
0.33 | MNOV | MediciNova | PairCorr |
0.32 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.32 | ESLAW | Estrella Immunopharma | PairCorr |
0.36 | ABEO | Abeona Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between OmniAb Stock performing well and OmniAb Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OmniAb's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
LEGN | 2.34 | (0.46) | 0.00 | (0.53) | 0.00 | 4.29 | 17.18 | |||
VRNA | 2.20 | 0.58 | 0.22 | 1.76 | 1.79 | 7.31 | 14.37 | |||
IDYA | 2.22 | (0.72) | 0.00 | (0.35) | 0.00 | 4.15 | 15.21 | |||
ITOS | 2.66 | (1.12) | 0.00 | (0.73) | 0.00 | 4.27 | 33.24 | |||
BCAB | 4.40 | (0.15) | (0.02) | 0.02 | 4.72 | 12.86 | 31.41 | |||
PASG | 5.07 | 0.03 | (0.01) | 0.20 | 5.92 | 10.00 | 25.50 | |||
PMVP | 1.55 | (0.03) | (0.03) | 0.07 | 1.99 | 3.75 | 13.98 | |||
IKNA | 0.90 | (0.11) | 0.00 | (0.09) | 0.00 | 1.80 | 5.87 | |||
OLMA | 2.91 | (0.41) | 0.00 | (0.06) | 0.00 | 6.17 | 19.19 |
OmniAb Corporate Management
Cia McCaffrey | Vice Talent | Profile | |
Donna CPA | Senior Controller | Profile | |
Bill Harriman | Senior Discovery | Profile | |
Douglas Krafte | Senior Head | Profile | |
MarieCecile DVM | Senior Genetics | Profile | |
Charles JD | Chief Secretary | Profile |